| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Sep―04 |
Abstract 7 2023 Update: Development of COVID-19 Therapies from Birthing Tissues and Cord Blood |
Frances Verter, Pedro Silva Couto |
| 2 |
[GO] |
2023―Mar―17 |
Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome |
Beth H Shaz, Bryan D Kraft, Jesse D Troy, Emily Poehlein, Lingye Chen, Lynn Cheatham, et al. (+7) Raha Manyara, Khalid Hanafy, Linda Brown, Margaret Scott, Ralph Palumbo, Frank Vrionis, Joanne Kurtzberg |
| 3 |
[GO] |
2022―Sep―08 |
Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study |
Martin Grumet, Jason Sherman, Barry S Dorf |
| 4 |
[GO] |
2022―Sep―06 |
Abstract 10 Interim Results of a Phase I Study Investigating a Cord Blood-Derived Natural Killer Cell Therapy for Patients Hospitalized with COVID-19 |
Almudena Tercero, Dan Finlay, Liya H Asghedom, Gladys R Romasanta, Natalie T Rice, Fatima Ranjbaran, et al. (+5) Carrie Stoltzman, Jody Cook, Joe Blake, Colleen Delaney, Joshua A Hill |
| 5 |
[GO] |
2022―Sep―06 |
Abstract 19 Cleveland Cord Blood Center (CCBC) Best Practices Throughout the COVID-19 Pandemic and How It Impacted Collection of Cord Blood Units |
Kathy Bobik-Kurz, Candice Laster, JoAnn Chase, Susan Boucher, Bridget Wood, Mary Laughlin, Marcie Finney |
| 6 |
[GO] |
2022―Sep―06 |
Abstract 12 Phase I Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome |
Bryan Kraft, Linda Brown, Margaret Scott, Frank Vrionis, Ralph Palumbo, Jesse Troy, et al. (+7) Emily Poehlein, Lynn Cheatham, Lingye Chen, Joanne Kurtzberg, Raha Manyara, Khalid Hanafy, Beth Shaz |
| 7 |
[GO] |
2022―Jun―27 |
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval-FASTER Approval |
Aidan M Kirkham, Adrian J M Bailey, Madeline Monaghan, Risa Shorr, Manoj M Lalu, Dean A Fergusson, David S Allan |
| 8 |
[GO] |
2021―Sep―18 |
2021 Update: Development of COVID-19 Therapies from Birthing Tissues and Cord Blood |
Frances Verter, Pedro Silva Couto |
| 9 |
[GO] |
2021―Jul―24 |
SARS-CoV
-2 research using human pluripotent stem cells and organoids |
Sayaka Deguchi, Ángel Serrano-Aroca, Murtaza M. Tambuwala, Bruce D. Uhal, Adam M. Brufsky, Kazuo Takayama |
| 10 |
[GO] |
2021―Mar―12 |
In the eye of the storm:
SARS-CoV-2
infection and replication at the ocular surface? |
Lyle Armstrong, Joseph Collin, Islam Mostafa, Rachel Queen, Francisco C. Figueiredo, Majlinda Lako |
| 11 |
[GO] |
2020―Nov―14 |
Human mesenchymal stromal cells do not express
ACE2
and
TMPRSS2
and are not permissive to
SARS-CoV
-2 infection |
Maria A. Avanzini, Manuela Mura, Elena Percivalle, Francesca Bastaroli, Stefania Croce, Chiara Valsecchi, et al. (+8) Elisa Lenta, Giulia Nykjaer, Irene Cassaniti, Jessica Bagnarino, Fausto Baldanti, Marco Zecca, Patrizia Comoli, Massimiliano Gnecchi |
| 12 |
[GO] |
2020―Sep―23 |
Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating
SARS-CoV
-2 infection to enable drug discovery and repurposing |
Sally Esmail, Wayne R. Danter |
| 13 |
[GO] |
2020―Aug―21 |
Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective |
Abbas Shafiee, Lida Moradi, Mayasari Lim, Jason Brown |
| 14 |
[GO] |
2020―Jul―22 |
The rationale of using mesenchymal stem cells in patients with
COVID-19
-related acute respiratory distress syndrome: What to expect |
Alp Can, Hakan Coskun |
| 15 |
[GO] |
2020―Apr―22 |
Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019 |
Fanpu Ji, Liya Li, Zongfang Li, Yan Jin, Wenjia Liu |
|
